Pasritamig is a bispecific antibody designed to target KLK2 and CD3E. It is structured as a (H-??1_L-??)_scFvkh-G1(h-CH2-CH3) type, combining specificity to both antigens. This configuration enhances its application in directing immune system components to tumor cells expressing KLK2, thereby facilitating targeted immunotherapy. Pasritamig is primarily used in research focused on cancer therapy modalities, particularly in studies investigating prostate cancer and immune cell engagement mechanisms.
Pasritamig is a bispecific antibody designed to target KLK2 and CD3E. It is structured as a (H-??1_L-??)_scFvkh-G1(h-CH2-CH3) type, combining specificity to both antigens. This configuration enhances its application in directing immune system components to tumor cells expressing KLK2, thereby facilitating targeted immunotherapy. Pasritamig is primarily used in research focused on cancer therapy modalities, particularly in studies investigating prostate cancer and immune cell engagement mechanisms.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
